Doylestown, PA, United States of America

Brian Blakey

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Brian Blakey: Innovator in Atherosclerosis Treatment

Introduction

Brian Blakey is a notable inventor based in Doylestown, PA (US). He has made significant contributions to the field of medical treatments, particularly focusing on atherosclerosis. With a total of two patents to his name, Blakey's work is paving the way for innovative therapeutic approaches.

Latest Patents

Blakey's latest patents revolve around methods for the treatment of atherosclerosis. The first patent discloses methods and compositions for preventing or treating atherosclerosis in a mammalian subject. The methods involve administering an effective amount of an aromatic-cationic peptide, and in some applications, a second active agent, to subjects in need thereof. The second patent similarly focuses on the treatment or prevention of atherosclerosis through the administration of a therapeutically effective amount of aromatic cationic peptides, with the potential inclusion of a second active agent chemically linked to the peptide.

Career Highlights

Brian Blakey is currently associated with Stealth Biotherapeutics Inc., where he continues to develop innovative solutions for medical challenges. His work is characterized by a commitment to advancing therapeutic methods that can significantly impact patient care.

Collaborations

Some of his notable coworkers include D Travis Wilson and Mark J Bamberger, who contribute to the collaborative efforts in research and development at Stealth Biotherapeutics Inc.

Conclusion

Brian Blakey's contributions to the treatment of atherosclerosis through innovative methods and compositions highlight his role as a key inventor in the medical field. His ongoing work promises to enhance therapeutic options for patients suffering from this condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…